These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8578513)

  • 21. Protease-activated G protein-coupled receptors on human platelets and endothelial cells.
    Brass LF; Molino M
    Thromb Haemost; 1997 Jul; 78(1):234-41. PubMed ID: 9198159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. G-protein-coupled receptors as signaling targets for antiplatelet therapy.
    Smyth SS; Woulfe DS; Weitz JI; Gachet C; Conley PB; Goodman SG; Roe MT; Kuliopulos A; Moliterno DJ; French PA; Steinhubl SR; Becker RC;
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):449-57. PubMed ID: 19023091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.
    Kuliopulos A; Covic L; Seeley SK; Sheridan PJ; Helin J; Costello CE
    Biochemistry; 1999 Apr; 38(14):4572-85. PubMed ID: 10194379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A role for thrombin receptor signaling in endothelial cells during embryonic development.
    Griffin CT; Srinivasan Y; Zheng YW; Huang W; Coughlin SR
    Science; 2001 Aug; 293(5535):1666-70. PubMed ID: 11533492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of potent thrombin receptor antagonist peptides.
    Bernatowicz MS; Klimas CE; Hartl KS; Peluso M; Allegretto NJ; Seiler SM
    J Med Chem; 1996 Dec; 39(25):4879-87. PubMed ID: 8960546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracellular mediators in atherosclerosis and thrombosis: lessons from thrombin receptor knockout mice.
    Major CD; Santulli RJ; Derian CK; Andrade-Gordon P
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):931-9. PubMed ID: 12676802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of novel peptide inhibitors of thrombin-induced platelet activation.
    Burke FM; Warnock M; Schmaier AH; Mosberg HI
    Chem Biol Drug Des; 2006 Nov; 68(5):235-8. PubMed ID: 17177882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombin and protease-activated receptors (PARs) in atherothrombosis.
    Martorell L; Martínez-González J; Rodríguez C; Gentile M; Calvayrac O; Badimon L
    Thromb Haemost; 2008 Feb; 99(2):305-15. PubMed ID: 18278179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intimal hyperplasia following vascular injury is not inhibited by an antisense thrombin receptor oligodeoxynucleotide.
    Herbert JM; Guy AF; Lamarche I; Mares AM; Savi P; Dol F
    J Cell Physiol; 1997 Feb; 170(2):106-14. PubMed ID: 9009139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteinase-activated receptors (PARs)--the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1.
    Kaufmann R; Schulze B; Krause G; Mayr LM; Settmacher U; Henklein P
    Regul Pept; 2005 Feb; 125(1-3):61-6. PubMed ID: 15582715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
    Kaufmann R; Rahn S; Pollrich K; Hertel J; Dittmar Y; Hommann M; Henklein P; Biskup C; Westermann M; Hollenberg MD; Settmacher U
    J Cell Physiol; 2007 Jun; 211(3):699-707. PubMed ID: 17323377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The thrombin receptor.
    Dennington PM; Berndt MC
    Clin Exp Pharmacol Physiol; 1994 May; 21(5):349-58. PubMed ID: 7955544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
    Wu CC; Teng CM
    Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombin receptor antagonists: a work in progress.
    Brass LF
    Coron Artery Dis; 1997 Jan; 8(1):49-58. PubMed ID: 9101123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombin receptor. Variations on a theme.
    Lefkowitz RJ
    Nature; 1991 May; 351(6325):353-4. PubMed ID: 1851963
    [No Abstract]   [Full Text] [Related]  

  • 36. Thrombin receptor antagonists; recent advances in PAR-1 antagonist development.
    Anderluh M; Dolenc MS
    Curr Med Chem; 2002 Jul; 9(13):1229-50. PubMed ID: 12052165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms of thrombin signaling.
    Coughlin SR
    Semin Hematol; 1994 Oct; 31(4):270-7. PubMed ID: 7831572
    [No Abstract]   [Full Text] [Related]  

  • 38. Thrombin interactions with cells of the megakaryocytic lineage.
    Vittet D; Chevillard C
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):759-68. PubMed ID: 8292726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-thrombin receptors and growth signaling.
    Van Obberghen-Schilling E; Pouysségur J
    Semin Thromb Hemost; 1993; 19(4):378-85. PubMed ID: 8140430
    [No Abstract]   [Full Text] [Related]  

  • 40. Thrombin receptor structure and function.
    Coughlin SR; Scarborough RM; Vu TK; Hung DT
    Cold Spring Harb Symp Quant Biol; 1992; 57():149-54. PubMed ID: 1339654
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.